Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07134751) titled 'Febrile Infants Swedish Study' on Aug. 5. Study Type: Observational Primary... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136545) titled 'A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients Wi... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132892) titled 'Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy' on Aug. 5. Study Type: Inter... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1040250073) titled 'Suprapapillary stent-by-stent deployment with slim-fully covered metal... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111390) titled 'Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111442) titled 'A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Rena... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111507) titled 'A Study of Tarlatamab for People With Prostate Cancer' on Aug. 1. Study Type:... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111546) titled 'A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid T... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111663) titled 'An Observational Study of Individuals With Isolated Dystonia' on Aug. 1. Stud... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112274) titled 'Empagliflozin on Patients With Preserved Heart Failure' on Aug. 1. Study Type... Read More